Journal article
Use of oral moist tobacco (snus) in puberty and its association with asthma in the population-based RHINESSA study
JP López-Cervantes, V Schlünssen, C Senaratna, S Accordini, FJ Callejas, KA Franklin, M Holm, NO Jogi, A Malinovschi, A Oudin, T Sigsgaard, EH Thorarinsdottir, C Janson, RJ Bertelsen, C Svanes
BMJ Open Respiratory Research | BMJ PUBLISHING GROUP | Published : 2024
Abstract
Objectives To investigate the association of early snus use initiation (≤15 years of age) with asthma and asthma symptoms. Design Cross-sectional analysis of a population-based cohort. Setting Study centres in Norway, Sweden, Iceland, Denmark and Estonia, from 2016 to 2019. Participants 9002 male and female participants above 15 years of age of the Respiratory Health in Northern Europe, Spain and Australia study. Main outcome measures Current asthma and asthma symptoms. Results The median age of study participants was 28 years (range 15-53) and 58% were women. 20% had used snus, 29% men and 14% women. Overall, 26% of males and 14% of females using snus started ≤15 years of age. Early snus us..
View full abstractGrants
Awarded by NAV
Funding Acknowledgements
The lead author (JPL- C) received funding from the PhD scholarship from the University of Bergen. Coordination and establishment of the RHINESSA study has received funding from the Research Council of Norway (Grants No. 274767, 214123, 228174, 230827 and 273838), ERC StG project BRuSH #804199, the European Union's Horizon 2020 Research and Innovation Program under grant agreement No. 633212 (the ALEC Study WP2), the Bergen Medical Research Foundation and the Western Norwegian Regional Health Authorities (Grants No. 912011, 911892 and 911631). Study centres have further received local funding from the following: Bergen: the above grants, Worldwide Universities Network (REF and Sustainability grants), Norwegian Labour Inspection (NAV), the Norwegian Asthma and Allergy Association. Albacete and Huelva: Sociedad Espanola de Neumologia y Cirugia Toracica (SEPAR) Fondo de Investigacion Sanitaria (FIS PS09). Gothenburg, Umea and Uppsala: the Swedish Heart and Lung Foundation (Hjaert- Lungefonden), the Swedish Asthma and Allergy Association (Astma- och Allergifoerbundet). Reykjavik: University of Iceland (Haskoli & Iacute;slands). Melbourne: National Health and Medical Research Council NHMRC Project Grant ID1128450, University of Melbourne. Tartu: The Estonian Research Council (Grant No. PUT562). Aarhus: The Danish Wood Foundation (Grant No. 444508795), the Danish Working Environment Authority (Grant No. 20150067134), Aarhus University (PhD scholarship).